New insights into a complex mechanism that contributes to the growth of telomeres, the repetitive sequences of DNA that protect the end of a cell’s chromosomes, may lead to future cancer treatments.
Let's Epicure, a startup created by Rachel Wang, MBA '15, Claire Lambrecht '06, MBA '15, and Miwa Takaki, MBA '15 won a $10,000 business competition prize for their company, which helps with healthy eating.
In the late 19th century, Cornell students enjoyed visually striking class lectures and extracurricular talks thanks to lantern slides – 4-by-3.25-inch projected glass slides that illustrated all subjects.
In a new book, a Weill Cornell Medicine physician argues for advocacy and awareness on behalf of people with severe brain injuries who risk becoming deeply marginalized.
Cornell scientists participated in Grow: Urban Garden Symposium in New York City Oct. 14, advising new and experienced gardeners on techniques and procedure to grow produce in the city.
Cornell University, in partnership with Memorial Sloan Kettering Cancer Center, is opening a new $10 million MSKCC-Cornell Center for Translation of Cancer Nanomedicines. The center is based on development of nanoparticles called C dots.
Cornell President Elizabeth Garrett heralded a future of greater collaboration between Ithaca and New York City at a Sept. 21 reception in honor of her inauguration as the university’s 13th president.
Minimally Invasive New Technologies Program (MINT) at Weill Cornell Medical College teamed with entrepreneurs to establish Lumendi, a start-up producing endoscopic tools for gastrointestinal surgery.
Researchers at the Caryl and Israel Englander Institute for Precision Medicine at Weill Cornell Medical College use genomic sequencing to understand factors that drive disease development and identify treatments most likely to be effective for each patient.
